NCT07170150 A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Status RECRUITING Phase PHASE3
NCT07169578 A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Status RECRUITING Phase PHASE3
NCT07163611 Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study Status RECRUITING Phase PHASE2/PHASE3
NCT07161258 A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS) Status RECRUITING Phase PHASE2
NCT07158242 A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis Status RECRUITING Phase PHASE3
NCT07137598 A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) Status RECRUITING Phase PHASE2
NCT07137585 A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07112872 A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07081958 A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07074886 A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) Status RECRUITING Phase PHASE2
NCT07059273 A COPD Data Registry for Participants With Frequent Exacerbations Status NOT_YET_RECRUITING Phase N/A
NCT07054190 A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer Status RECRUITING Phase PHASE2
NCT07025811 A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT07012980 Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06998524 A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease Status RECRUITING Phase PHASE3
NCT06993142 Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage Status NOT_YET_RECRUITING Phase NA
NCT06982131 A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants Status RECRUITING Phase PHASE1
NCT06975436 Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis Status COMPLETED Phase N/A
NCT06965413 A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06961370 A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) Status ACTIVE_NOT_RECRUITING Phase PHASE1